Table I.
Study Population Characteristics According to Left Ventricular Geometric Abnormalities (LVGAs)
| All Patients (N=81) | Patients With LVGAs (n=19) | Patients Without LVGAs (n=66) | P Value | |
|---|---|---|---|---|
| Age, y | 58.9±13.7 | 65.1±11.0 | 57.2±14.0 | .03 |
| Male sex, % | 31 (36.5) | 11 (57.9) | 20 (30.2) | .03 |
| Age of hypertension diagnosis, y | 47.2±13.0 | 54.3±11.9 | 45.2±12.7 | .01 |
| Years of hypertension | 11.8±10.1 | 10.8±8.9 | 12.0±10.5 | .64 |
| Systolic blood pressure, mm Hg | 132.2±13.4 | 133.4±14.9 | 131.9±13.0 | .66 |
| Diastolic blood pressure, mm Hg | 75.3±11.4 | 75.5±15.1 | 75.2±10.3 | .93 |
| Body mass index, kg/m2 | 30.9±5.7 | 30.5±5.6 | 31.0±5.8 | .74 |
| Dyslipidemia, % | 38 (44.7) | 7 (37.0) | 31 (47.0) | .43 |
| Smoker, % | 10 (11.8) | 4 (21.0) | 6 (9.1) | .22 |
| Family history of hypertension, % | 65 (76.5) | 12 (63.0) | 53 (80.3) | .12 |
| Patients treated with 2 drugs | 59 (69.4) | 15 (79.0) | 44 (66.7) | .31 |
| Medication | ||||
| Calcium channel blockers | 38 (44.7) | 8 (42.1) | 30 (45.5) | .80 |
| Diuretics | 28 (32.9) | 9 (47.4) | 19 (28.8) | .13 |
| Angiotensin‐converting enzyme inhibitors | 37 (43.5) | 9 (47.4) | 28 (42.4) | .70 |
| β‐Blockers | 29 (34.1) | 4 (21.1) | 25 (37.9) | .17 |
| α‐Blockers | 4 (4.7) | 2 (10.5) | 2 (3.0) | .22 |
| Angiotensin receptors blockers | 7 (8.2) | 2 (10.5) | 5 (7.6) | .65 |